Apolipoprotein E exhibits isoform‐specific promotion of lipid efflux from astrocytes and neurons in culture
Abstract
Many studies have shown that apolipoprotein E (apoE) plays important roles in maintaining intracellular lipid homeostasis in nonneuronal cells. However, little is known about the extracellular transport of lipids in the CNS. In this study, we determined whether and to what degree lipid efflux from astrocytes and neurons depended on apoE. Our results showed that exogenously added apoE promoted the efflux of cholesterol and phosphatidylcholine from both astrocytes and neurons in culture, resulting in the generation of high-density lipoprotein-like particles. The order of potency of the apoE isoforms as lipid acceptors was apoE2 > apoE3 = apoE4 in astrocytes and apoE2 > apoE3 > apoE4 in neurons. Treatment with brefeldin A, monensin, and a protein kinase C inhibitor, H7, abolished the ability of apoE to promote cholesterol efflux from cultured astrocytes, without altering apoE-mediated phosphatidylcholine efflux. In contrast, the efflux of both cholesterol and phosphatidylcholine promoted by apoE was abolished following treatment with heparinase or lactoferrin, which block the interaction of apoE with heparan sulfate proteoglycans (HSPGs) or low-density lipoprotein receptor-related protein (LRP), respectively. This study suggests that apoE promotes lipid efflux from astrocytes and neurons in an isoform-specific manner and that cell surface HSPGs and/or HSPG-LRP pathway may mediate this apoE-promoted lipid efflux.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
APOE2 is the most efficient at promoting cholesterol efflux, and APOE4 is the least efficient, correlating inversely with AD risk.
“While APOE2 is the most efficient at promoting cholesterol efflux, APOE4 is the least efficient, correlating inversely with AD risk.”
From Deletion of neuronal <i>Idol</i> ameliorates Alzheimer's disease–related pathologies via APOE receptors (2025) · cites this paper as [66]
APOE isoforms differ in their ability to regulate lipid metabolism and cholesterol efflux.
“One key difference among APOE isoforms is their ability to regulate lipid metabolism and cholesterol efflux.”
From Deletion of neuronal <i>Idol</i> ameliorates Alzheimer's disease–related pathologies via APOE receptors (2025) · cites this paper as [66]
No citation lists for this paper
No citation lists for this paper yet — checked again daily.
References 53 · Cited by 244
- Authors
- Michikawa, M., Fan, Q., Isobe, I., & Yanagisawa, K.
- Venue
- Journal of Neurochemistry
- Publisher
- Wiley
- Published
- 2000-03
- Volume
- 74
- Issue
- 3
- Pages
- 1008-1016
- ISSN
- 0022-3042 (ISSN-L)
- 1471-4159
- OpenAlex
- W2047397116
- Cited by
- 244
- References
- 53
- Citations by year
- 2026: 4 · 2025: 9 · 2024: 12 · 2023: 8 · 2022: 14 · 2021: 8 · 2020: 10 · 2019: 6 · 2018: 5 · 2017: 5 · 2016: 7 · 2015: 4 · 2014: 12 · 2013: 9 · 2012: 10
- FWCI
- 14.77
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Journal of Neurochemistry (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Core Research for Evolutional Science and Technology
- Topics
- Health Sciences › Medicine › Surgery › Cholesterol and Lipid Metabolism
- Health Sciences › Medicine › Physiology › Alzheimer's disease research and treatments
- Health Sciences › Medicine › Surgery › Lipoproteins and Cardiovascular Health
- Keywords
- apolipoprotein E, APOE isoforms, lipid efflux, cholesterol efflux, astrocytes, neurons, heparan sulfate proteoglycans, LRP, brefeldin A, monensin, protein kinase C, lipid homeostasis
- MeSH terms
- Animals, Apolipoproteins E, Astrocytes, Cells, Cultured, Cholesterol, Dose-Response Relationship, Drug, Enzyme Inhibitors, Monensin, Neurons, Phosphatidylcholines, Protein Kinase C, 1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine, Protein Isoforms, Brefeldin A, Lipid Metabolism, Rats
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review